Cited by 283Pregnancy and preeclampsia studiesBirth, Development, and HealthPI3K/AKT/mTOR signaling in cancer

Mammalian target of rapamycin in the human placenta regulates leucine transport and is down‐regulated in restricted fetal growth

Open access
Roos, Sara, Jansson, Nina, Palmberg, Isabelle, Säljö, Karin, Powell, Theresa L., Jansson, Thomas·2007·The Journal of Physiology

Abstract

Pathological fetal growth is associated with perinatal morbidity and the development of diabetes and cardiovascular disease later in life. Placental nutrient transport is a primary determinant of fetal growth. In human intrauterine growth restriction (IUGR) the activity of key placental amino acid transporters, such as systems A and L, is decreased. However the mechanisms regulating placental nutrient transporters are poorly understood. We tested the hypothesis that the mammalian target of rapamycin (mTOR) signalling pathway regulates amino acid transport in the human placenta and that the activity of the placental mTOR pathway is reduced in IUGR. Using immunohistochemistry and culture of trophoblast cells, we show for the first time that the mTOR protein is expressed in the transporting epithelium of the human placenta. We further demonstrate that placental mTOR regulates activity of the l‐amino acid transporter, but not system A or taurine transporters, by determining the mediated uptake of isotope‐labelled leucine, methylaminoisobutyric acid and taurine in primary villous fragments after inhibition of mTOR using rapamycin. The protein expression of placental phospho‐S6K1 (Thr‐389), a measure of the activity of the mTOR signalling pathway, was markedly reduced in placentas obtained from pregnancies complicated by IUGR. These data identify mTOR as an important regulator of placental amino acid transport, and provide a mechanism for the changes in placental leucine transport in IUGR previously demonstrated in humans. We propose that mTOR functions as a placental nutrient sensor, matching fetal growth with maternal nutrient availability by regulating placental nutrient transport.

Integrity signals

Registry

Crossref · 10.1113/jphysiol.2007.129676

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Reduced p-S6K1, but no change in p-4E-BP1, was observed in placentas with growth restriction of unknown origin.

    “Reduced p-S6K1, but no change in p-4E-BP1, was observed in placentas with growth restriction of unknown origin (468).”

    From Placental Origins of Chronic Disease (2016) · cites this paper as [468]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Roos, S., Jansson, N., Palmberg, I., Säljö, K., Powell, T. L., & Jansson, T.
Affiliations
  • University of Gothenburg (SE)
  • University of Cincinnati (US)
Venue
The Journal of Physiology
Publisher
Wiley
Published
2007-06-25
Volume
582
Issue
1
Pages
449-459
ISSN
  • 0022-3751 (ISSN-L)
  • 1469-7793
OpenAlex
W2160209138
Cited by
283
References
54
Citations by year
2026: 5 · 2025: 11 · 2024: 8 · 2023: 10 · 2022: 12 · 2021: 24 · 2020: 18 · 2019: 20 · 2018: 17 · 2017: 21 · 2016: 18 · 2015: 22 · 2014: 23 · 2013: 17 · 2012: 19
FWCI
10.95
Type
journal article
Language
en
Open access
Locations
  • The Journal of Physiology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Stiftelserna Wilhelm och Martina Lundgrens
  • Vetenskapsrådet
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
mTOR signaling, human placenta, fetal growth restriction, leucine transport, amino acid transport, placental nutrient transport, S6K1 phosphorylation, rapamycin, trophoblast, taurine transport
MeSH terms
Adult, Birth Weight, Cells, Cultured, Chorionic Villi, Dose-Response Relationship, Drug, Epithelial Cells, Female, Fetal Growth Retardation, Gestational Age, Humans, Immunohistochemistry, Infant, Newborn, Leucine, Phosphoproteins, Placenta, Pregnancy, Protein Kinases, Trophoblasts, Signal Transduction, Down-Regulation, Cell Cycle Proteins, Sirolimus, Amino Acid Transport System L, Adaptor Proteins, Signal Transducing, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review